Redkiewicz P, Dyniewicz J, Misicka A
Int J Mol Sci. 2021; 22(21).
PMID: 34768778
PMC: 8582929.
DOI: 10.3390/ijms222111347.
Matalinska J, Lipinski P, Kosson P, Kosinska K, Misicka A
Int J Mol Sci. 2020; 21(20).
PMID: 33086743
PMC: 7588979.
DOI: 10.3390/ijms21207738.
Starnowska J, Costante R, Guillemyn K, Popiolek-Barczyk K, Chung N, Lemieux C
ACS Chem Neurosci. 2017; 8(10):2315-2324.
PMID: 28699350
PMC: 5647227.
DOI: 10.1021/acschemneuro.7b00226.
Dyniewicz J, Lipinski P, Kosson P, Lesniak A, Bochynska-Czyz M, Muchowska A
ACS Med Chem Lett. 2017; 8(1):73-77.
PMID: 28105278
PMC: 5238479.
DOI: 10.1021/acsmedchemlett.6b00381.
Giri A, Apostol C, Wang Y, Forte B, Largent-Milnes T, Davis P
J Med Chem. 2015; 58(21):8573-83.
PMID: 26465170
PMC: 5769151.
DOI: 10.1021/acs.jmedchem.5b01170.
Synthesis and biological evaluation of compact, conformationally constrained bifunctional opioid agonist - neurokinin-1 antagonist peptidomimetics.
Guillemyn K, Kleczkowska P, Lesniak A, Dyniewicz J, Van der Poorten O, Van den Eynde I
Eur J Med Chem. 2014; 92:64-77.
PMID: 25544687
PMC: 4336569.
DOI: 10.1016/j.ejmech.2014.12.033.
Investigational peptide and peptidomimetic μ and δ opioid receptor agonists in the relief of pain.
Giri A, Hruby V
Expert Opin Investig Drugs. 2013; 23(2):227-41.
PMID: 24329035
PMC: 4282681.
DOI: 10.1517/13543784.2014.856879.
In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist-neurokinin 1 receptor antagonist chimera.
Guillemyn K, Kleczkowska P, Novoa A, Vandormael B, Van den Eynde I, Kosson P
Mol Brain. 2012; 5:4.
PMID: 22289619
PMC: 3284447.
DOI: 10.1186/1756-6606-5-4.
Design of novel neurokinin 1 receptor antagonists based on conformationally constrained aromatic amino acids and discovery of a potent chimeric opioid agonist-neurokinin 1 receptor antagonist.
Ballet S, Feytens D, Buysse K, Chung N, Lemieux C, Tumati S
J Med Chem. 2011; 54(7):2467-76.
PMID: 21413804
PMC: 3096782.
DOI: 10.1021/jm1016285.
Discovery of a potent and efficacious peptide derivative for δ/μ opioid agonist/neurokinin 1 antagonist activity with a 2',6'-dimethyl-L-tyrosine: in vitro, in vivo, and NMR-based structural studies.
Yamamoto T, Nair P, Largent-Milnes T, Jacobsen N, Davis P, Ma S
J Med Chem. 2011; 54(7):2029-38.
PMID: 21366266
PMC: 3090346.
DOI: 10.1021/jm101023r.
Biological and conformational evaluation of bifunctional compounds for opioid receptor agonists and neurokinin 1 receptor antagonists possessing two penicillamines.
Yamamoto T, Nair P, Jacobsen N, Kulkarni V, Davis P, Ma S
J Med Chem. 2010; 53(15):5491-501.
PMID: 20617791
PMC: 2943425.
DOI: 10.1021/jm100157m.
Improving metabolic stability by glycosylation: bifunctional peptide derivatives that are opioid receptor agonists and neurokinin 1 receptor antagonists.
Yamamoto T, Nair P, Jacobsen N, Vagner J, Kulkarni V, Davis P
J Med Chem. 2010; 52(16):5164-75.
PMID: 20560643
PMC: 3521585.
DOI: 10.1021/jm900473p.
The biological activity and metabolic stability of peptidic bifunctional compounds that are opioid receptor agonists and neurokinin-1 receptor antagonists with a cystine moiety.
Yamamoto T, Nair P, Ma S, Davis P, Yamamura H, Vanderah T
Bioorg Med Chem. 2009; 17(20):7337-43.
PMID: 19762245
PMC: 2775479.
DOI: 10.1016/j.bmc.2009.08.035.
The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists.
Yamamoto T, Nair P, Jacobsen N, Davis P, Ma S, Navratilova E
J Med Chem. 2008; 51(20):6334-47.
PMID: 18821747
PMC: 2675940.
DOI: 10.1021/jm800389v.
A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists.
Yamamoto T, Nair P, Vagner J, Largent-Milnes T, Davis P, Ma S
J Med Chem. 2008; 51(5):1369-76.
PMID: 18266313
PMC: 2737825.
DOI: 10.1021/jm070332f.
Design, synthesis, and biological evaluation of novel bifunctional C-terminal-modified peptides for delta/mu opioid receptor agonists and neurokinin-1 receptor antagonists.
Yamamoto T, Nair P, Davis P, Ma S, Navratilova E, Moye S
J Med Chem. 2007; 50(12):2779-86.
PMID: 17516639
PMC: 2365895.
DOI: 10.1021/jm061369n.
